[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-447133-105":59,"doc-detail-447133-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","demodex-blepharitis-treatment-with-a-selenium-sulfide-containing-ointment-a-case-report","Demodex Blepharitis Treatment with a Selenium Sulfide-Containing Ointment - A Case Report","","Demodex blepharitis is a chronic, progressive inflammatory disorder of the eyelids driven by overgrowth of Demodex mites, causing ocular irritation, erythema, and discomfort. This case study evaluated AZR-MD-001, a selenium sulfide-containing ophthalmic ointment, in a patient with chronic Demodex blepharitis using treated and vehicle-controlled periods. AZR 0.5% led to resolution with no Demodex mites, while the vehicle period showed return or no change. No adverse events were reported; further studies are needed to confirm safety and efficacy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/demodex-blepharitis-treatment-with-a-selenium-sulfide-containing-ointment-a-case-report/447133/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/demodex-blepharitis-treatment-with-a-selenium-sulfide-containing-ointment-a-case-report/447133.png","ImageObject",300,407,{"name":92,"@type":93},"Mafia Boss","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-29",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What condition does the case report address?","Question",{"text":112,"@type":113},"The report addresses Demodex blepharitis, a chronic, progressive eyelid inflammation driven by overgrowth of Demodex mites.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was AZR-MD-001 administered in the patient?",{"text":117,"@type":113},"The patient applied AZR 0.5% to the right lower eyelid every other day at bedtime for 6 weeks, used a vehicle control for 6 weeks, then applied AZR 0.5% to both lower eyelids twice a week for 6 weeks.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the outcomes and were any adverse events reported?",{"text":121,"@type":113},"After AZR 0.5% treatment, blepharitis resolved in the treated eye with no evidence of Demodex mites. Signs returned during the discontinued/vehicle-controlled period, and no adverse events were reported.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},447133,1790906713,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},962090760730,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","TherapeuTic advances in  \nOphthalmology Case Report  \nDemodex blepharitis treatment with a selenium sulfide-containing ointment:  \na case report  \nYair Alster, Omer Rafaeli and Charles Bosworth  \nAbstract: Demodex blepharitis is a chronic, progressive condition characterized by inflammation, ocular irritation, and erythema due to an overgrowth of mites in hair folliclesand oil glands of the eyelids. AZR-MD-001(AZR) is a selenium sulfide-containing ophthalmic ointment that is a potential treatment option for Demodex blepharitis. We wished to complete a case study to identify the potential of this agent to treat Demodex blepharitis. A patient with chronic Demodex blepharitis applied AZR 0.5% to the right lower eyelid every other day at bedtime for 6 weeks, discontinued treatment for 6 weeks, then treated the left lower eyelid with vehicle only for 6 weeks, followed by use of AZR 0. 5% for both lower eyelids twice a week for 6 weeks. Eyelashes were removed and pooled for evidence of mites and collarettes before and after the first treatment, and eyes were inspected for signs of blepharitis before and after each treatment period. After treatment with AZR 0.5%, resolution of blepharitis occurred in the treated eye, with no evidence of Demodex mites. The untreated eye showed no difference from baseline. After discontinuing for 6 weeks, the signs of blepharitis returned, similar to baseline. After 6 weeks of vehicle application to the left eye, no changes in signs were observed. After treatment with AZR 0.5% for 6 weeks to both eyes, complete resolution of blepharitis occurred in both eyes. No adverse events were reported. Treatment with AZR 0.5% was efficacious in eradicating Demodex blepharitis, which was not evidenced when using vehicle or a lack of treatment. This demonstrated a potential new use for AZR to treat Demodex blepharitis. Further studies are required to establish the safety and efficacy of this product.  \nPlain language summary  \nTreatment of a patient with chronic Demodex blepharitis using an ointment containing selenium sulfide  \nBlepharitis is a chronic condition with symptoms that include swelling and itching of the eyelids, and irritation of the eyes, and is commonly caused by an overgrowth of the Demodex mite on eyelids. Products with selenium sulfide have been shown to treat blepharitis, but these products have been difficult for patients to tolerate due to their other ingredients. AZR-MD-001 is an ointment that contains selenium sulfide that is applied to the margin of the eyelids and has been shown to relieve itching of the eyes in other studies. This case report describes the use of AZR-MD-001 in one eye of a patient who had an ongoing history of Demodex blepharitis over a period of several weeks, while the other eye was only treated with the carrier of the drug without the active ingredient (called the vehicle) to act as a control. The patient showed improvement in their blepharitis in the treated eye, with no change in the control eye. This suggests that Demodex blepharitis could be a potential use for this ointment. Further studies are needed to investigate the use of AZRMD-001 in the treatment of patients with this condition.  \nTherAdv Ophthalmol 2026, Vol. 18: 1–7  \nDOI: 10. 1177/ 25158414251405397 © The Author(s), 2026.  \nArticle reuse guidelines: [sagepub.com/journals](sagepub.com/journals)permissions  \nCorrespondence to:  \nYair Alster  \nAzura Ophthalmics Ltd, 5 Druyanov Street, Tel Aviv 6314305, Israel  \nyair.alster@  \n[azuraophthalmics.com](azuraophthalmics.com)  \nOmer Rafaeli  \nCharles Bosworth  \nAzura Ophthalmics Ltd, Tel Aviv, Israel  \n[journals.sagepub.com/home/oed](journals.sagepub.com/home/oed) 1  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License  \n([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction an","cbCaidfNTfCs8zQx","https://ap.wps.com/l/cbCaidfNTfCs8zQx","pdf",1318535,"English","# Abstract\n## Plain language summary\n## Keywords\n## Introduction","[{\"question\":\"What condition does the case report address?\",\"answer\":\"The report addresses Demodex blepharitis, a chronic, progressive eyelid inflammation driven by overgrowth of Demodex mites.\"},{\"question\":\"How was AZR-MD-001 administered in the patient?\",\"answer\":\"The patient applied AZR 0.5% to the right lower eyelid every other day at bedtime for 6 weeks, used a vehicle control for 6 weeks, then applied AZR 0.5% to both lower eyelids twice a week for 6 weeks.\"},{\"question\":\"What were the outcomes and were any adverse events reported?\",\"answer\":\"After AZR 0.5% treatment, blepharitis resolved in the treated eye with no evidence of Demodex mites. Signs returned during the discontinued/vehicle-controlled period, and no adverse events were reported.\"}]","Demodex Blepharitis Treatment with a Selenium Sulfide-Containing Ointment - A Case Report | PDF",1790718930,18]